Bullish case
$19.13 to $22.32
More likely if Cellebrite DI Ltd. sustains revenue growth above 20%, margins expand further, and the stock re-rates toward analyst targets amid strong government and enterprise demand.
Cellebrite DI Ltd. research snapshot
CLBT AI Stock Analysis
CLBT AI stock analysis currently reads Cellebrite DI Ltd. as a digital intelligence and forensics software company with strong government and enterprise customer penetration, high switching costs from certified workflows and training, and improving recurring revenue. At the July 12, 2026 cutoff, the quoted price was $15.94 and market capitalization was about $3.98 billion. The main decision point was whether steady revenue growth, expanding margins, and a large addressable market can sustain the current valuation multiple. This is informational research and not investment advice.
Current price
$15.94
Market cap
$3.98 billion
AI score
63 / 100
Rating
Niche leader, execution risk
Trend status
Consolidating near top of range
Data cutoff (updated weekly)
July 12, 2026
Informational use only. This page is not investment advice.
Research quality check
- information Richness
- B-level information richness. Cellebrite has public filings since its 2021 SPAC merger, moderate analyst coverage (6 analysts), and detailed product disclosures. Limited non-US government customer breakdown.
- bias Check
- The AI bias risk is the niche nature of the business: digital forensics for law enforcement may be underappreciated by generalist models. The analysis separates verified financials from qualitative judgments about government procurement cycles.
- ai Confidence
- Medium-high data confidence
- investment Certainty
- Medium. The business sits in a defensible niche with high switching costs, but valuation multiples reflect a premium for specialized revenue that may not expand further.
Quick verdict table
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Cellebrite sells digital forensics software and services to law enforcement, government, and enterprise customers for legally sanctioned investigations. | Medium-high |
| Moat | Moat comes from certified workflows and training lock-in, government procurement relationships, regulatory compliance barriers, and brand trust in the forensic community. | Medium-high |
| Management | Management has execution credibility from stable revenue growth and margin improvement, but insider selling by the CEO and CFO in recent months signals a watch point. | Medium |
| Financial trend | Revenue and net income were verified mechanically. Steady growth and cash generation confirmed; two-source financial statement checks remain recommended before investment use. | Medium |
| Valuation | At 57x trailing earnings and 7.9x sales, the stock prices in continued growth. Margin of safety depends on whether revenue accelerates or the multiple compresses. | Medium-low |
| Technical trend | Consolidating near the top of a wide 52-week range. Use live moving averages, support, resistance, momentum, volume, and invalidation levels before acting. | Medium |
| Risk level | The thesis can fail if government budgets tighten, privacy regulations limit digital forensics tools, competition emerges, or key customer concentration creates revenue risk. | Medium-high |
| AI confidence | Medium-high data confidence for qualitative mapping and quote math. Lower confidence for forward returns given the niche market dynamics. | Medium-high |
| Investment certainty | Medium certainty because the page gives a framework, not a personalized buy or sell instruction. The niche has defensibility but limited growth acceleration visibility. | Medium |
CLBT AI stock forecast
CLBT AI Stock Forecast Scenarios
The CLBT AI stock forecast uses scenario ranges around the $15.94 quote rather than a point target. The bullish case requires continued government spending growth and expanding enterprise adoption; the base case assumes steady organic growth at current multiples; the bearish case assumes budget or regulatory headwinds compress the multiple.
Base case
$14.35 to $18.83
More likely if fundamentals remain steady with mid-teens revenue growth, stable margins, and the stock trades around current multiples while investors watch for the next earnings cycle.
Bearish case
$9.56 to $13.23
More likely if these risk paths appear: government budget cuts reduce procurement, privacy regulation limits tool deployment, or competition from Palantir, MSAB, or open-source alternatives erodes the competitive position, and technical support breaks.
CLBT AI technical analysis
CLBT AI Technical Analysis
CLBT AI technical analysis starts from the $15.94 quote. Because this static page does not fetch request-time chart data, moving averages and live momentum should be confirmed in a charting tool before use.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $15.94 | Current quote used for this page as of the July 10, 2026 market close. |
| Near support | $14.40 to $15.10 | Estimated from recent consolidation and prior price action. Treat as a planning zone, not a guaranteed floor. |
| Near resistance | $16.60 to $17.80 | Estimated from the upper half of the 52-week range. A clean break above this zone with volume would signal renewed momentum. |
| 52-week high | $19.98 | The upper boundary of the price range from the past year. A move above this level would require a significant catalyst. |
| 52-week low | $11.02 | Lower boundary of the trailing 52-week range, well below the current price. |
| 50-day moving average | Requires live chart confirmation | Use current chart data before acting. The page does not fetch request-time market data. |
| 200-day moving average | Requires live chart confirmation | Long-term trend confirmation should be checked against a live chart or broker data. |
| Momentum | Consolidating, trend neutral | Price has pulled back from the upper end of the range. Volume and price action suggest the setup needs fresh catalyst confirmation. |
| Volume | Below average recent volume | Volume has been lower than the 2.2M average, which can reduce reliability of breakout and breakdown signals. |
| Volatility | Moderate monitoring priority | The stock has a beta of 1.17. Use position sizing that can tolerate moderate daily movement. |
| Invalidation | Close below $14.40 | A decisive close below the support zone would weaken the short-term setup. |
CLBT AI trading strategy
CLBT AI Trading Strategy Framework
The CLBT AI trading strategy is a rules-based research framework. It is not personalized advice and should be paired with position sizing, stop levels, and fresh filings or news checks.
Trend-following setup
Wait for CLBT to hold above the near support zone and push through the $16.60-$17.80 resistance area with volume that confirms renewed buyer demand, ideally after an earnings beat or contract win.
A close below the support zone or a failed breakout should invalidate the setup.
Mean-reversion setup
If CLBT dips into the $14.40-$15.10 support band without a thesis-changing event, evaluate the government budget outlook and competitive landscape before considering a position.
Do not average down without a predefined maximum loss and a fresh review of the business risk.
Fundamental monitor
Track the evidence that matters most for digital forensics: revenue growth rate, gross margin trend, recurring revenue percentage, government contract wins, and regulatory developments.
Reduce confidence when price moves are driven by headlines without matching financial evidence or when insider selling accelerates.
Investment research summary
Four-master Research Compression
Business essence
Cellebrite sells digital forensics software and services that let law enforcement, government agencies, and enterprises extract, analyze, and manage digital evidence from mobile devices and cloud sources for legally sanctioned investigations.
Moat
Cellebrites moat comes from certified workflow lock-in through investigator training programs, deep government procurement relationships that take years to displace, regulatory and chain-of-custody compliance requirements, and brand trust built over 25 years in the digital forensics community.
Munger risk inversion
The thesis can fail if government budgets tighten and delay procurement cycles, privacy regulation limits digital forensics tool deployment, a well-funded competitor like Palantir or Axon enters the niche more aggressively, or decryption and mobile security advances make current extraction methods less effective.
Management
Management has shown execution capability with consistent revenue growth, expanding margins, and positive free cash flow. The CEO and CFO insider selling in mid-2026 is a watch point that requires monitoring for pattern rather than a single signal.
Industry trend
Digital evidence volumes are growing exponentially as mobile device usage and cloud storage expand. Law enforcement agencies globally are investing in digital investigation capabilities, placing Cellebrite in a long-term secular growth trend.
Valuation and margin of safety
At 57x trailing earnings and 7.9x sales, the stock embeds an expectation of continued growth. Margin of safety depends on whether the company can sustain mid-to-high teens revenue growth and whether the market maintains its willingness to pay a premium for niche software exposure.
Source-backed data
CLBT Data Table
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| CLBT price | $15.94 | Current quote snapshot cross-checked with MarketBeat and Yahoo Finance | July 12, 2026 |
| Market capitalization | $3.98 billion, verified as $15.94 x ~249.44 million implied shares | MarketBeat and Yahoo Finance market cap data | July 12, 2026 |
| Exchange | NasdaqGS | Yahoo Finance and public quote pages | July 12, 2026 |
| Trading volume snapshot | 1.37 million (recent) / 2.23 million average | MarketBeat and Yahoo Finance | July 12, 2026 |
| P/E ratio (TTM) | 56.93 | MarketBeat | July 12, 2026 |
| Revenue (TTM) | $496.43 million | Yahoo Finance | July 12, 2026 |
| Cash and short-term investments | $429.07 million | Yahoo Finance | July 12, 2026 |
| Financial statement depth | Public filings available. Two-source statement checks still required before investment use. | Research quality check | July 12, 2026 |
Frequently Asked Questions
Use Pineify AI Stock PickerBuild an AI trading strategyRun an AI stock screenerRead the CGNT AI stock analysis
This CLBT AI stock analysis page is an informational tool only. It is not investment advice, a recommendation, or a promise of future returns. Forecast scenarios are based on available data as of July 12, 2026, may be incomplete, and can be wrong if new filings, market prices, company events, or macro conditions change.
Related Tools
Trading Strategy Builder
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Try it
Stock Screener
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Try it
AI Stock Picker & Screener
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
Try it